Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2017-10-19 2017-10-19
Drug Identification Number 00030619 00030619
Brand name SOLU-CORTEF 250 MG ACT-O-VIAL SOLU-CORTEF 250 MG ACT-O-VIAL
Common or Proper name Solu-Cortef Solu-Cortef
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROCORTISONE HYDROCORTISONE
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10x2mL 10x2mL
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2017-09-30 2017-09-30
Actual start date
Estimated end date 2017-10-11 2017-10-11
Actual end date 2017-10-18 2017-10-18
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Other formats are available Other formats are available
Health Canada comments